Login / Signup

Future needs for informed consent in stem cell clinical trials in neurodegenerative diseases.

Natalie HellmersYaa Obeng-AduasareInmaculada de Melo-MartínClaire Henchcliffe
Published in: Neural regeneration research (2016)
Keyphrases
  • stem cells
  • clinical trial
  • current status
  • phase ii
  • open label
  • study protocol
  • randomized controlled trial
  • mesenchymal stem cells